DE69006187D1 - Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren. - Google Patents
Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren.Info
- Publication number
- DE69006187D1 DE69006187D1 DE90121632T DE69006187T DE69006187D1 DE 69006187 D1 DE69006187 D1 DE 69006187D1 DE 90121632 T DE90121632 T DE 90121632T DE 69006187 T DE69006187 T DE 69006187T DE 69006187 D1 DE69006187 D1 DE 69006187D1
- Authority
- DE
- Germany
- Prior art keywords
- ones
- isoquinolyloxazol
- contagiousness
- quinolyl
- glycoproteins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 241000700605 Viruses Species 0.000 title abstract 2
- ZINIIQBSXNSVBO-UHFFFAOYSA-N 4-isoquinolin-1-yl-3h-1,3-oxazol-2-one Chemical class O1C(=O)NC(C=2C3=CC=CC=C3C=CN=2)=C1 ZINIIQBSXNSVBO-UHFFFAOYSA-N 0.000 title 1
- 102000003886 Glycoproteins Human genes 0.000 title 1
- 108090000288 Glycoproteins Proteins 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 208000030507 AIDS Diseases 0.000 abstract 1
- 208000031886 HIV Infections Diseases 0.000 abstract 1
- 229940123924 Protein kinase C inhibitor Drugs 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003881 protein kinase C inhibitor Substances 0.000 abstract 1
- 230000009385 viral infection Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US43531889A | 1989-11-13 | 1989-11-13 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69006187D1 true DE69006187D1 (de) | 1994-03-03 |
| DE69006187T2 DE69006187T2 (de) | 1994-05-05 |
Family
ID=23727911
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE90121632T Expired - Fee Related DE69006187T2 (de) | 1989-11-13 | 1990-11-12 | Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren. |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0428105B1 (de) |
| JP (1) | JP2927930B2 (de) |
| KR (1) | KR0162639B1 (de) |
| AT (1) | ATE100318T1 (de) |
| AU (1) | AU630249B2 (de) |
| DE (1) | DE69006187T2 (de) |
| DK (1) | DK0428105T3 (de) |
| ES (1) | ES2062266T3 (de) |
| IE (1) | IE63851B1 (de) |
| PH (1) | PH27309A (de) |
| ZA (1) | ZA908933B (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6107327A (en) * | 1996-08-30 | 2000-08-22 | Eli Lilly And Company | Therapeutic treatment for HIV infection |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4886811A (en) * | 1988-10-24 | 1989-12-12 | Merrell Dow Pharmaceuticals | Qunolyloxazole-2-ones useful as proteinkinase C inhibitors |
-
1990
- 1990-11-03 PH PH41540A patent/PH27309A/en unknown
- 1990-11-07 ZA ZA908933A patent/ZA908933B/xx unknown
- 1990-11-08 AU AU65929/90A patent/AU630249B2/en not_active Ceased
- 1990-11-12 EP EP90121632A patent/EP0428105B1/de not_active Expired - Lifetime
- 1990-11-12 ES ES90121632T patent/ES2062266T3/es not_active Expired - Lifetime
- 1990-11-12 KR KR1019900018247A patent/KR0162639B1/ko not_active Expired - Fee Related
- 1990-11-12 IE IE407990A patent/IE63851B1/en not_active IP Right Cessation
- 1990-11-12 DK DK90121632.5T patent/DK0428105T3/da active
- 1990-11-12 AT AT90121632T patent/ATE100318T1/de not_active IP Right Cessation
- 1990-11-12 DE DE90121632T patent/DE69006187T2/de not_active Expired - Fee Related
- 1990-11-13 JP JP2304165A patent/JP2927930B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| PH27309A (en) | 1993-05-28 |
| KR910009260A (ko) | 1991-06-28 |
| KR0162639B1 (ko) | 1998-12-01 |
| EP0428105A2 (de) | 1991-05-22 |
| DE69006187T2 (de) | 1994-05-05 |
| IE63851B1 (en) | 1995-06-14 |
| JPH03173886A (ja) | 1991-07-29 |
| IE904079A1 (en) | 1991-05-22 |
| ATE100318T1 (de) | 1994-02-15 |
| EP0428105B1 (de) | 1994-01-19 |
| AU6592990A (en) | 1991-05-16 |
| JP2927930B2 (ja) | 1999-07-28 |
| AU630249B2 (en) | 1992-10-22 |
| EP0428105A3 (en) | 1991-12-11 |
| ZA908933B (en) | 1991-08-28 |
| DK0428105T3 (da) | 1994-02-28 |
| ES2062266T3 (es) | 1994-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69535758D1 (de) | Lipid-analoge zur behandlung von viralen infektionen | |
| EA200600582A1 (ru) | Способы и композиции для лечения вирусного гепатита с | |
| DE60105424D1 (de) | Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden | |
| UA66744C2 (en) | 5,6-dichlorobenzimidazole derivatives, methods for the preparation thereof, pharmaceutical composition and method for treatment of viral infections | |
| ATE231549T1 (de) | Verfahren zur konservierung von infektiösen rekombinierenden viren, virale wässrige suspension und ihre medizinische verwendung | |
| ATE219366T1 (de) | Verwendung von 5-fluoro-2'-deoxy-3'-thiacytidin zur behandlung von hepatitis b | |
| ES2123156T3 (es) | Compuestos y procedimientos de inhibicion de hiv y virus semejantes. | |
| DE3686108D1 (de) | Verwendung von p-chlorophenoxyazetat von n,n-dimethylbiguanid zur behandlung von neuropathien und nervendegeneration. | |
| ATE189394T1 (de) | Methode zur behandlung von viralen infektionen | |
| EA199800526A1 (ru) | Производные бензимидазола и их применение для лечения вирусных инфекций | |
| ATE253368T1 (de) | Verwendung von bisphosphonaten zur prophylaxe und zur behandlung von infektiösen prozessen | |
| DE69939604D1 (de) | Kombinationstherapie zur Behandlung von Hepatitis B Infektionen | |
| ATE213231T1 (de) | Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren | |
| DE69019404D1 (de) | Derivate von Penciclovir zur Behandlung von Hepatitis-B-Infektionen. | |
| DE69006187D1 (de) | Verwendung von Chinolyl- und Isochinolyloxazol-2-onen zur Herstellung eines Arzneimittels zur Verhinderung der Ansteckungsfähigkeit von mit Glykoproteinen umhüllten Viren. | |
| DE3767308D1 (de) | Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels. | |
| ATE155795T1 (de) | Verwendung von leukoregulin zur behandlung von mit einem envelope-virus infizierten tier | |
| DE69010523D1 (de) | Kit oder Zusammensetzung zur Vorbeugung oder Behandlung von HIV-1 Infektionen. | |
| ATE255417T1 (de) | Verwendung von bradykinin-antagonisten zur behandlung von viruserkrankungen | |
| DE69210737D1 (de) | Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen | |
| DE69231465D1 (de) | Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten | |
| DE69932741D1 (de) | Verwendung von n-glycolneuraminsäure und deren derivaten zur herstellung eines medikaments zur behandlung von hiv-infektionen | |
| DE68919301D1 (de) | Verwendung eines Prolylendopeptidase-Inhibitors zur Behandlung von AIDS. | |
| FI943295A0 (fi) | Piliostigma thonningii -uutteet, niiden käyttö ja Piliostigma thonningii -uutteet, niiden käyttö ja niitä sisältävät formuloinnit niitä sisältävät formuloinnit | |
| MX9400210A (es) | Tratamiento de infecciones virales. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |